![Vincent Aurentz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincent Aurentz
Directeur/Membre du Conseil chez
INHIBIKASE THERAPEUTICS, INC.
Fortune : 893 543 $ au 31/05/2026
Profil
Vincent E.
Aurentz is currently Chairman at DoveTail Integrated Systems, Inc., Independent Director at Inhibikase Therapeutics, Inc. starting in 2025, and Director at Forward Therapeutics, Inc. Former positions include President & Director at HemoShear Therapeutics, Inc. (2015), Independent Director at Longboard Pharmaceuticals, Inc. (2020–2024), Partner at Computer Sciences Corp., Executive Vice President at Quintiles Transnational Corp.
(2010–2012), Executive Vice President at Merck KGaA, Chief Business Officer & Executive Vice President at Arena Pharmaceuticals, Inc. (2016–2022), Chief Commercial Officer at Merck Serono SA (2002–2009), Partner at Csc Healthcare Systems, Inc. (1997–1999), Executive Vice President-Customer Solutions at IQVIA Clinical AB (2010–2012), Chief Business Officer at EPIRUS Biopharmaceuticals, Inc. (2015–2016), and Principal at Catenion GmbH (2012–2014).
Education includes undergraduate studies at Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 510 596 ( 0,39% ) | 893 543 $ | 31/05/2026 |
Postes actifs de Vincent Aurentz
| Sociétés | Poste | Début |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/02/2025 |
DoveTail Integrated Systems, Inc.
 DoveTail Integrated Systems, Inc. BiotechnologyHealth Technology Develops biotechnology bio-pharmaceutical products | Président | - |
Forward Therapeutics, Inc.
 Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Vincent Aurentz
| Sociétés | Poste | Fin |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/12/2024 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2022 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2016 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | President | 01/11/2015 |
Catenion GmbH
 Catenion GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/12/2014 |
Formation de Vincent Aurentz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Computer Sciences Corp.
 Computer Sciences Corp. Information Technology ServicesTechnology Services Provides IT services | Technology Services |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Commercial Services |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Health Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Csc Healthcare Systems, Inc. | |
IQVIA Clinical AB
 IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology Specializes in primary care, hospital and specialist products | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
DoveTail Integrated Systems, Inc.
DoveTail Integrated Systems, Inc. BiotechnologyHealth Technology Develops biotechnology bio-pharmaceutical products | Health Technology |
EPIRUS Biopharmaceuticals, Inc.
 EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Catenion GmbH
Catenion GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Forward Therapeutics, Inc.
Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Health Technology |
